CIENCIAS DE LA SALUD
Departamento
Mayo Clinic
Rochester, Estados UnidosPublicacions en col·laboració amb investigadors/es de Mayo Clinic (9)
2020
-
Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)
Acta Neuropathologica
-
Global Survey on Telemedicine Utilization for Movement Disorders During the COVID-19 Pandemic
Movement Disorders, Vol. 35, Núm. 10, pp. 1701-1711
-
Implementation of Telemedicine for Urgent and Ongoing Healthcare for Patients with Parkinson's Disease During the COVID-19 Pandemic: New Expectations for the Future
Journal of Parkinson's disease
2018
-
A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers
Brain, Vol. 141, Núm. 10, pp. 2895-2907
-
Telemedicine Use for Movement Disorders: A Global Survey
Telemedicine and e-Health, Vol. 24, Núm. 12, pp. 979-992
-
The Promise of Telemedicine for Movement Disorders: an Interdisciplinary Approach
Current Neurology and Neuroscience Reports, Vol. 18, Núm. 5
2017
-
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
Nature Genetics, Vol. 49, Núm. 9, pp. 1373-1384
2016
-
Genome-wide association study in essential tremor identifies three new loci
Brain, Vol. 139, Núm. 12, pp. 3163-3169
2014
-
The past, present, and future of telemedicine for Parkinson's disease
Movement Disorders, Vol. 29, Núm. 7, pp. 871-883